Cargando…
Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts
Autores principales: | Hayward, Catherine P.M., Tasneem, Subia, Rivard, Georges E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754410/ https://www.ncbi.nlm.nih.gov/pubmed/33205919 http://dx.doi.org/10.1111/ijlh.13311 |
Ejemplares similares
-
Thrombin generation abnormalities in Quebec platelet disorder
por: Brunet, Justin G., et al.
Publicado: (2020) -
Thrombopoietin levels in Quebec platelet disorder—Implications for the mechanism of thrombocytopenia
por: Hayward, C. P. M., et al.
Publicado: (2018) -
The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes
por: Hayward, Catherine P. M., et al.
Publicado: (2017) -
Bleeding risks for uncharacterized platelet function disorders
por: Brunet, Justin, et al.
Publicado: (2020) -
Platelet count and platelet indices in women with preeclampsia
por: AlSheeha, Muneera A, et al.
Publicado: (2016)